Indications

The WELL Program is specifically designed for lifestyle optimization through the use of our ground-breaking technique of the Ketamine-Induced Transpersonal Experience, coupled with innovative techniques of preventative medicine and transpersonal psychology.

Ketamine-Enhanced Psychedelic Psychotherapy assists conscious personal transformation away from unhealthy lifestyle habits such as poor diet, lack of exercise, or behavioral addictions. It also works well treating existential problems, transpersonal issues, and mid-life metamorphosis. In addition, it is useful in the treatment of other various addictions, anxiety, phobias, post-traumatic stress disorder, psychosomatic illnesses, depression, hypochondrias, neurotic personality disorders, and death anxiety in individuals dying from terminal illnesses.

At the Kolp Institute, we do not specialize in the treatment of drug addictions, mental illnesses, or psychosomatic disorders. Our primary goal is to assist clients with lifestyle optimization and acceleration of psychospiritual growth. However, clients who have concurrent emotional problems in addition to their existential and psychospiritual concerns may still be accepted into the WELL Program .

Contraindications

The Kolp Institute does not maintain an emergency department, nor does it provide medical treatment in all disciplines of medicine. Therefore, the WELL Program does not accept those individuals with clinically unstable disorders, including cardiovascular, hepatic, renal, gastrointestinal, pulmonary, metabolic, endocrine, neurological, or other systemic diseases.

Those with clinically unstable psychiatric disorders characterized by psychotic symptoms, such as dementia, schizophrenia or bipolar disorder, are also not appropriate candidates. The WELL Program does not accept people with the presence of suicidal ideations.

The experience of Ketamine is much more profound when there is no previous history of the use of “psychedelic” drugs. Therefore, a history of repeated use of hallucinogenic compounds diminishes the effects of the Ketamine experience and may significantly decrease the results of the treatment.

Certain other medications, such as benzodiazepines, opiates and barbiturates, may interact adversely with or obscure the action of Ketamine. Therefore, those who take any of these medications would not benefit from our program.

The effects of Ketamine on an unborn child are not known. Therefore, pregnant women, nursing mothers and women who can have children, but who are not using effective birth control, are not candidates for the WELL Program .

Ketamine-Enhanced Psychedelic Psychotherapy has not been studied on children and the elderly; therefore, the program is open only to individuals between the ages of 18 and 64.